NCT06023121View on ClinicalTrials.gov

Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer

CompletedOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

August 1, 2023

Study Completion Date

August 30, 2023

Conditions
Gastric Cancer
Interventions
DIAGNOSTIC_TEST

Measurement of levels of an exosome-based liquid biopsy signature

Each participant was enrolled to assess the levels of an exosome-based liquid biopsy signature

Trial Locations (1)

100853

Chinese PLA General Hospital Ethics Committee, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER

NCT06023121 - Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer | Biotech Hunter | Biotech Hunter